Bridge Funding for Disrupted Neurodegenerative Research Grant Program (BFDN) Powering the Next Generation of Research

About this funding opportunity

Animations

Home Page

Save for later

Bridge Funding for Disrupted Neurodegenerative Research Grant Program (BFDN) Powering the Next Generation of Research

Donate Now

Funding Opportunities Save for later Bridge Funding for Disrupted Neurodegenerative Research Grant Program (BFDN) Powering the Next Generation of Research

Objective:

The Alzheimer’s Association and The Michael J. Fox Foundation for Parkinson’s Research are launching the Bridge Funding for Disrupted Neurodegenerative Research (BFDN) grant program.

U.S. federal government-sponsored research funding has experienced a series of changes that challenges ongoing research initiatives and the future of the U.S. biomedical research enterprise. Maintaining continuity of funding for these projects enables further scientific progress and is critical to millions of Americans affected by Alzheimer’s disease, Parkinson’s disease, and other neurodegenerative disorders and age-related causes of dementia, and millions more who may be affected by these diseases in the future, as rates for neurological disease are increasing around the world and expected to double as age is the biggest risk factor.

Recent advances in Alzheimer’s and Parkinson’s disorders research show tremendous promise, and ensuring funding for priority research grants is vital for investigators to effectively and efficiently perform life-saving research and carry- out public health programs toward better health outcomes for the United States, and the world.

As the world’s largest nonprofit funders with a shared commitment and purpose to deliver better treatments and a cure for (respectively) Alzheimer’s, Parkinson’s and related disorders, the Alzheimer’s Association and The Michael J. Fox Foundation for Parkinson’s Research are launching the Bridge Funding for Disrupted Neurodegenerative Research (BFDN) grant program. The Alzheimer’s Association has partnered with the Robertson Foundation to support this unique funding program.

This program specifically aims to 1) ensure support for early career researchers (based on NIH definition), who have not yet had the opportunity to fully establish their labs and position their projects for ongoing funding, and 2) provide bridge or interim funding for salary and other direct costs for research projects focused on Alzheimer’s disease, Frontotemporal Dementia, Parkinson’s disease, Dementia with Lewy Bodies, atypical Parkinson's and/or other related disorders that have been impacted by a series of changes at NIH.

Funding and award period:

Principal investigators may apply for bridge funding spanning 3 to 12 months for U.S. and international projects impacted by changes in the NIH. Specific streams of funding include: Delayed Review: Projects stalled due to NIH review process delays. Termination: Laboratories whose NIH grants have been terminated due to changes in funding priorities and/or area of interest and are seeking other permanent funding. Priority Misalignment: Projects that no longer fit NIH focus areas requiring redirection to align with reframing to reflect adjusted priorities and areas of interest. Gaps: Previously funded projects awaiting reapproval under new criteria. Personnel Continuity: Salary support for key personnel due to changes in project timelines.

We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.

I Understand

a17495660521.cdn.optimizely.com a17495660521.cdn.optimizely.com is blocked

This page has been blocked by an extension Try disabling your extensions.

ERR_BLOCKED_BY_CLIENT

Reload

This page has been blocked by an extension

Topic areas: Life Sciences and Health.

Funding amount

This grant provides Varies in funding.

Deadline

Applications are accepted on a rolling basis; there is no single fixed deadline.

Who can apply

This opportunity is open to the following applicant types:

• Not specified by the program.

Eligibility

The program did not publish a separate eligibility statement. See the official opportunity page for the full eligibility criteria.

Agency

Bridge Funding for Disrupted Neurodegenerative Research Grant Program (BFDN) Powering the Next Generation of Research is administered by Michael J. Fox Foundation (MJFF), listed via Michael J. Fox Foundation.